Trademark: 74042453
Status Date
Friday, January 29, 2016
Registration Number
1667974
Registration Date
Tuesday, December 10, 1991
Filing Date
Monday, March 26, 1990
Published for Opposition
Tuesday, February 5, 1991
Cancellation Date
Friday, January 29, 2016
5 immune globulin intravenous (human) which is a plasma derivative manufactured from human plasma for immune replacement in primary or acquired immune deficient states or to modulate auto immune disorders
Jan 29, 2016
Cancelled Sec. 8 (10-Yr)/Expired Section 9
Aug 15, 2011
Attorney Revoked And/Or Appointed
Aug 15, 2011
Teas Revoke/Appoint Attorney Received
Feb 11, 2010
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 11, 2010
Teas Change Of Owner Address Received
Dec 10, 2007
Case File In Ticrs
Dec 4, 2007
Teas Change Of Correspondence Received
Jul 8, 2002
Registered And Renewed (First Renewal - 10 Yrs)
Jul 8, 2002
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
May 1, 2002
Registered - Combined Section 8 (10-Yr) & Sec. 9 Filed
Jul 9, 1997
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Jun 4, 1997
Registered - Sec. 8 (6-Yr) & Sec. 15 Filed
Dec 10, 1991
Registered-Principal Register
Sep 27, 1991
Allowed Principal Register - Sou Accepted
Sep 17, 1991
Assigned To Examiner
Sep 4, 1991
Statement Of Use Processing Complete
Jul 8, 1991
Use Amendment Filed
Apr 30, 1991
Noa Mailed - Sou Required From Applicant
Feb 5, 1991
Published For Opposition
Jan 4, 1991
Notice Of Publication
Oct 15, 1990
Approved For Pub - Principal Register
Oct 3, 1990
Examiner's Amendment Mailed
Aug 22, 1990
Correspondence Received In Law Office
Aug 22, 1990
Examiner's Amendment Mailed
Jul 18, 1990
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
